Used in research as a structural analog in the development of antitumor agents, particularly targeting DNA-interacting compounds. Shows potential in studies related to topoisomerase inhibition, which may interfere with cancer cell replication. Also investigated for its intercalative properties in nucleic acids, making it a candidate in the design of novel chemotherapeutic agents. Limited to laboratory and preclinical studies; not approved for clinical use.